BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33153140)

  • 1. Can Magnetic Resonance Radiomics Analysis Discriminate Parotid Gland Tumors? A Pilot Study.
    Gabelloni M; Faggioni L; Attanasio S; Vani V; Goddi A; Colantonio S; Germanese D; Caudai C; Bruschini L; Scarano M; Seccia V; Neri E
    Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33153140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of qualitative and radiomics approach to parotid gland tumors: which is the added benefit of texture analysis?
    Vernuccio F; Arnone F; Cannella R; Verro B; Comelli A; Agnello F; Stefano A; Gargano R; Rodolico V; Salvaggio G; Lagalla R; Midiri M; Lo Casto A
    Br J Radiol; 2021 Dec; 94(1128):20210340. PubMed ID: 34591597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of T2-weighted-based radiomics model in distinguishing Warthin tumor from pleomorphic adenoma of the parotid.
    Hu Z; Guo J; Feng J; Huang Y; Xu H; Zhou Q
    Eur Radiol; 2023 Jun; 33(6):4453-4463. PubMed ID: 36502461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla.
    Fruehwald-Pallamar J; Czerny C; Holzer-Fruehwald L; Nemec SF; Mueller-Mang C; Weber M; Mayerhoefer ME
    NMR Biomed; 2013 Nov; 26(11):1372-9. PubMed ID: 23703801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of a Novel Ultrasonographic Classification Based on Anechoic Area Patterns for Differentiating Warthin Tumors from Pleomorphic Adenomas of the Parotid Gland.
    Matsuda E; Fukuhara T; Donishi R; Kawamoto K; Hirooka Y; Takeuchi H
    Yonago Acta Med; 2017 Dec; 60(4):220-226. PubMed ID: 29434491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of MRI-based radiomic features for distinguishing Warthin tumor from pleomorphic adenoma: performance assessment using T2-weighted and post-contrast T1-weighted MR images.
    Faggioni L; Gabelloni M; De Vietro F; Frey J; Mendola V; Cavallero D; Borgheresi R; Tumminello L; Shortrede J; Morganti R; Seccia V; Coppola F; Cioni D; Neri E
    Eur J Radiol Open; 2022; 9():100429. PubMed ID: 35757232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced CT-based texture analysis and radiomics score for differentiation of pleomorphic adenoma, basal cell adenoma, and Warthin tumor of the parotid gland.
    Chen F; Ge Y; Li S; Liu M; Wu J; Liu Y
    Dentomaxillofac Radiol; 2023 Jan; 52(2):20220009. PubMed ID: 36367128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent diffusion coefficient (ADC) histogram analysis: differentiation of benign from malignant parotid gland tumors using readout-segmented diffusion-weighted imaging.
    Zhang Z; Song C; Zhang Y; Wen B; Zhu J; Cheng J
    Dentomaxillofac Radiol; 2019 Oct; 48(7):20190100. PubMed ID: 31265331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Benign From Malignant Parotid Gland Tumors Using Conventional MRI Based on Radiomics Nomogram.
    Qi J; Gao A; Ma X; Song Y; Zhao G; Bai J; Gao E; Zhao K; Wen B; Zhang Y; Cheng J
    Front Oncol; 2022; 12():937050. PubMed ID: 35898886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep Learning for Differentiating Benign From Malignant Parotid Lesions on MR Images.
    Xia X; Feng B; Wang J; Hua Q; Yang Y; Sheng L; Mou Y; Hu W
    Front Oncol; 2021; 11():632104. PubMed ID: 34249680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent Diffusion Coefficient Map-Based Radiomics Features for Differential Diagnosis of Pleomorphic Adenomas and Warthin Tumors From Malignant Tumors.
    Wen B; Zhang Z; Zhu J; Liu L; Li Y; Huang H; Zhang Y; Cheng J
    Front Oncol; 2022; 12():830496. PubMed ID: 35747827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics-based comparison of MRI and CT for differentiating pleomorphic adenomas and Warthin tumors of the parotid gland: a retrospective study.
    Liu Y; Zheng J; Lu X; Wang Y; Meng F; Zhao J; Guo C; Yu L; Zhu Z; Zhang T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 May; 131(5):591-599. PubMed ID: 33602604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Parotid Tumors With Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted MR Imaging.
    Abdel Razek AA; Samir S; Ashmalla GA
    J Comput Assist Tomogr; 2017 Jan; 41(1):131-136. PubMed ID: 27636248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Analysis and Pathological Basis of Signal Intensity on T2-Weighted MR Images in Benign and Malignant Parotid Tumors.
    Wei P; Shao C; Tian M; Wu M; Wang H; Han Z; Hu H
    Cancer Manag Res; 2021; 13():5423-5431. PubMed ID: 34262350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT-based radiomics with various classifiers for histological differentiation of parotid gland tumors.
    Lu Y; Liu H; Liu Q; Wang S; Zhu Z; Qiu J; Xing W
    Front Oncol; 2023; 13():1118351. PubMed ID: 36969052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging of parotid tumors: typical lesion characteristics in MR imaging improve discrimination between benign and malignant disease.
    Christe A; Waldherr C; Hallett R; Zbaeren P; Thoeny H
    AJNR Am J Neuroradiol; 2011 Aug; 32(7):1202-7. PubMed ID: 21724574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization?
    Yabuuchi H; Matsuo Y; Kamitani T; Setoguchi T; Okafuji T; Soeda H; Sakai S; Hatakenaka M; Nakashima T; Oda Y; Honda H
    Radiology; 2008 Dec; 249(3):909-16. PubMed ID: 18941162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent Diffusion Coefficient (ADC) Histogram Analysis in Parotid Gland Tumors: Evaluating a Novel Approach for Differentiation between Benign and Malignant Parotid Lesions Based on Full Histogram Distributions.
    Hepp T; Wuest W; Heiss R; May MS; Kopp M; Wetzl M; Treutlein C; Uder M; Wiesmueller M
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of parotid gland tumors by using multimodal MRI and deep learning.
    Chang YJ; Huang TY; Liu YJ; Chung HW; Juan CJ
    NMR Biomed; 2021 Jan; 34(1):e4408. PubMed ID: 32886955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsule of parotid gland tumor: evaluation by 3.0 T magnetic resonance imaging using surface coils.
    Ishibashi M; Fujii S; Kawamoto K; Nishihara K; Matsusue E; Kodani K; Kaminou T; Ogawa T
    Acta Radiol; 2010 Dec; 51(10):1103-10. PubMed ID: 20883183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.